Work

Interim analysis of a phase II study of nivolumab/ipilimumab plus cabozantinib in patients with unresectable advanced melanoma.

Year: 2023

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2023.41.16_suppl.9563

Authors: Geoffrey Thomas Gibney, Andrew L Pecora, Suthee Rapisuwon, Kevin Chen, Kellie Gardner, Gayle Cramer, Danielle Blair, Amy Avergas, Nicole Swanson, Jaeil Ahn, Michael B. Atkins

Institutions: Georgetown Lombardi Comprehensive Cancer Center, Hackensack University Medical Center, MedStar Franklin Square Medical Center, Georgetown University Medical Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Exelixis

OpenAlex ID: W4379340541

Cites:

Cited by: 3

Related to: 10